Back to search results

Usability Study of the eWave Patch for Heart Monitoring

This study is testing the WearLinq eWave patch, a wearable device that continuously tracks your heart rhythm (ECG monitoring). Researchers want to see how easy and effective the eWave patch is for adults, including those with heart disease or irregular heartbeats (arrhythmia). You might be able to join if you are an adult over 18, can use a smartphone app, and are willing to shave the area where the patch will be placed. The main goals are to measure how long people wear the patch and to track any side effects over 7 days. The current recruitment status is unclear, but the study plans to enroll 500 participants.

Study design
This is an interventional study planning to enroll 500 adult participants. It is evaluating the usability of a multi-channel ECG monitoring device.
What's involved
You would apply the WearLinq patch and wear it for 7 consecutive days. A smaller group might wear it for 30 days.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints are measured at 7 days after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07388355

A Usability Study of a Multi-channel ECG Monitoring Device

Recruiting
NAAges 18+InterventionalSupportive care
Wearlinq
~500 participants
Updated 2026-07-21 on ClinicalTrials.gov
What's tested:eWave Patch

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Wear Duration
Measured over 7 Days
+1 more outcome measured

Conditions

Healthy Adult Participants
Heart Disease
Arrythmia
Cardiac

Explore related trials

ArrhythmiaHealthy Adult ParticipantsHeart Disorder

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Chris Daniel · STUDY_DIRECTOR · WearLinq, Inc.

Who to contact

Andrea Brown, MS
[email protected]
408-881-2611
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adult \>18 years old and able to consent
Capable of using a smartphone app
Willing to shave patch area if needed

Exclusion

Planning to undergo an MRI during the study period
Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results
Presence of pacemaker, ICD or other implanted electronic devices
Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum)
Pregnant or intending to become pregnant during the course of the study

What this trial measures

  • Wear Duration7 Days

    Days of use until one of the following is reached: patch no longer adheres, signal loss, voluntary removal, or 7 days is achieved

  • Adverse Events7 Days

    Incidences of self-reported adverse events for the duration of the study